Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cabergoline: a long-acting dopamine agonist in Parkinson's disease.

× No keyword cloud information.

6 in total

1. Early treatment of Parkinson's disease with cabergoline delays the onset of motor complications. Results of a double-blind levodopa controlled trial. The PKDS009 Study Group.

Authors: U K Rinne; F Bracco; C Chouza; E Dupont; O Gershanik; J F Marti Masso; J L Montastruc; C D Marsden
Journal: Drugs Date: 1998 Impact factor: 9.546

Review 2. Pharmacological strategies for the management of levodopa-induced dyskinesia in patients with Parkinson's disease.

Authors: Eva Schaeffer; Andrea Pilotto; Daniela Berg
Journal: CNS Drugs Date: 2014-12 Impact factor: 5.749

3. Comparative Review of Dopamine Receptor Agonists in Parkinson's Disease.

Authors: R J Uitti; J E Ahlskog
Journal: CNS Drugs Date: 1996-05 Impact factor: 5.749

4. Double-blind study of the activity and tolerability of cabergoline versus placebo in parkinsonians with motor fluctuations.

Authors: M J Steiger; T El-Debas; T Anderson; L J Findley; C D Marsden
Journal: J Neurol Date: 1996-01 Impact factor: 4.849

Review 5. Clinical pharmacokinetics of cabergoline.

Authors: Paolo Del Dotto; Ubaldo Bonuccelli
Journal: Clin Pharmacokinet Date: 2003 Impact factor: 6.447

Review 6. Clinical pharmacology of dopamine agonists in Parkinson's disease.

Authors: K W Lange
Journal: Drugs Aging Date: 1998-11 Impact factor: 4.271

6 in total